CURRENT ISSUES OF EPIDEMIOLOGY, ETIOLOGY, RISK FACTORS AND PREDISPOSING CONDITIONS OF ACUTE PYELONEPHRITIS (REVIEW - PART I)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

A growing body of research indicates an upward trend in the incidence of urinary tract infections (UTIs) around the world. Acute pyelonephritis (AP), which is dangerous by the development of complex, life-threatening conditions, is no exception. Today the demographic portrait, as well as the characteristics of the causative agents and predisposing conditions of this disease are a global issue for the entire scientific community. In order to assess the data available in the global literature on the issues of epidemiology, etiology and predisposing factors for the development of AP, the search for publications was performed in the medical literature databases The Cochrane Database, MEDLINE/PubMed Database, eLIBRARY, ClinicalKey. The presented material includes, among others, 43 sources over the past 10 years, of which 31 publications over the past 5 years: the largest and most representative studies reflecting the current situation with AP in the population among patients in certain areas and under various exogenous and endogenous conditions. This study opens a series of three reviews on the problem of AP, involving discussion of key aspects of pathogenesis AP. Analysis of the literature indicates fragmentation and limited data when comparing the incidence of AP in different countries and different periods of time. The complexity of the intranosological structure of the varieties of acute pyelonephritis today dictates the advisability of updating approaches to research in this area, and the disease itself dynamically evolves along with its etiological agents, the nature of social behavior of people and environmental conditions in general.

Full Text

Restricted Access

About the authors

M. I Kogan

Rostov State Medical University

Email: dept_kogan@mail.ru
Honored Scientist of the Russian Federation, M.D., Dr. Sc. (M), Full Prof.; Head, Dept. of Urology and Human Reproductive Health (with the Pediatric Urology and Andrology course) Rostov-on-Don, Russia

S. N Ivanov

Rostov State Medical University

Email: ivanovsergey19@gmail.com
student Rostov-on-Don, Russia

Y. L Naboka

Rostov State Medical University

Email: nagu22@mail.ru
M.D., Dr. Sc. (M), Full Prof.; Head, Dept. of Microbiology and Virology № 1 Rostov-on-Don, Russia

References

  1. Аполихин О.И., Сивков А.В., Бешлиев Д.А., Солнцева Т.В., Комарова В.А., Зайцевская Е.В. Анализ урологической заболеваемости в Российской Федерации в 2002-2009 годах, по данным официальной статистики. ЭКУ. 2011;1. URL: https://cyberleninka.ru/article/n/analiz-urologicheskoy-zabolevaemosti-v-rossiyskoy-federatsii-v-2002-2009-godah-po-dannym-ofitsialnoy-statistiki
  2. Лоран О. Б., Синякова Л. А., Косова И. В. Современные подходы к диагностике и лечению острого необструктивного пиелонефрита у женщин. МС. 2008; 1-2. URL: https://cyberleninka.ru/article/n/sovremennye-podhody-k-diagnostike-i-lecheniyu-ostrogo-neobstruktivnogo-pielonefrita-u-zhenschin
  3. Сурсякова К.И., Сафьянова Т.В. Некоторые эпидемиологические особенности заболеваемости гломерулярными и тубулоинтерстициальными болезнями почек и инфекциями мочевыводящих путей в алтайском крае. ЭКУ. 2017;4. URL: https://cyberleninka.ru/article/n/nekotorye-epidemiologicheskie-osobennosti-zabolevaemosti-glomerulyarnymi-i-tubulointerstitsialnymi-boleznyami-pochek-i
  4. Czaja C.A., Scholes D., Hooton T.M., Stamm W.E. Population-Based Epidemiologic Analysis of Acute Pyelonephritis. Clinical Infectious Diseases. 2007;45(3):273-280. doi: 10.1086/519268.
  5. Neumann I., Moore P. Pyelonephritis (acute) in non-pregnant women. BMJ Clin Evid. 2014;2014:0807.
  6. Kim B., Myung R., Kim J., Lee M.J., Pai H. Descriptive Epidemiology of Acute Pyelonephritis in Korea, 2010-2014: Population-based Study. J Korean Med Sci. 2018;33(49):e310. doi: 10.3346/jkms.2018.33.e310.
  7. Ki M. The Epidemiology of Acute Pyelonephritis in South Korea, 1997- 1999. American Journal of Epidemiology. 2004; 160(10):985-993. doi: 10.1093/aje/kwh308.
  8. Nicolle L.E., Friesen D., Harding G.K., Roos L.L. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis. 1996;22(6):1051-1056. doi: 10.1093/clinids/22.6.1051.
  9. Liu J.M., Chang Y.L., Hsu R.J., Su H.Y., Teng S.W., Chang F.W. The climate impact on female acute pyelonephritis in Taiwan: A population-based study. Taiwanese Journal of Obstetrics and Gynecology. 2017;56(4):437- 441. doi: 10.1016/j.tjog.2016.06.022.
  10. Cek M., Tandogdu Z., Wagenlehner F., Tenke P., Naber K., Bjerklund-Johansen T.E. Healthcare-associated urinary tract infections in hospitalized urological patients-- a global perspective: results from the GPIU studies 2003-2010. World J Urol. 2014;32(6):1587-1594. doi: 10.1007/s00345- 013-1218-9.
  11. Wagenlehner F., Tandogdu Z., Bartoletti R., et al. The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections. Pathogens. 2016;5(1):10. Doi: 10.3390/ pathogens5010010.
  12. Choe H.S., Lee S.J., Cho Y.H., et al. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother. 2018;24(4):278-283. doi: 10.1016/j.jiac.2017.11.013.
  13. Tae Kwon K., Ryu S.Y., Wie S.H., et al. Change in Clinical Characteristics of Community-Acquired Acute Pyelonephritis in South Korea: Comparison Between 2010-2011 and 2017-2018. Open Forum Infect Dis. 2019;6(Suppl 2):S530. doi: 10.1093/ofid/ofz360.1315.
  14. Colgan R., Williams M., Johnson J.R. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician. 2011;84(5):519-526.
  15. Bosch-Nicolau P., Falco V., Vinado B., et al. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis. Antimicrob Agents Chemother. 2017;61(12):e01317-17. 11. Doi:10.1128/ AAC.01317-17.
  16. Kogan M.I., Naboka Y.L., Klyuka I.V., Suchkov I.Y., Afoko A. Detection of viruses in bladder, renal pelvis urine and kidney bioptates in children with ob-struction of upper urinary tract. European urology supple-ments 21 st Annual Con-gress of European Association of Urology. 2006. P. 264.
  17. Коган М.И., Набока Ю.Л, Ибишев Х.С., Гудима И.А. Нестерильность мочи здорового человека - новая парадигма в медицине. Урология. 2014;5:48-52).
  18. Hilt E.E., McKinley K., Pearce M.M., et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871-876. Doi:10.1128/ JCM.02876-13.
  19. Aagaard K., Luna J. Versalovic. The Human Microbiome of Local Body Sites and Their Unique Biology. Principles and Practice of infectious Diseases. 2015;2:11-18.
  20. Набока Ю.Л., Ильяш А.В., Крахоткин Д.В. Вирусо-бактеральные ассоциации, верифицированные в моче здоровых людей (пилотное исследование). Вестник урологии. 2018;6(3):44-49) https://doi.org/10.21886/2308-6424-2018-6-3-44-49
  21. Набока Ю.Л., Коган М.И., Гудима И.А., Ибишев Х.С., Черницкая М.Л., Джалагония К.Т., Иванов С.Н. Микробиота мочи, уретры и эякулята здорового человека. Инфекции и воспаления в урологии. 2019;18-34).
  22. Коган М.И., Набока Ю.Л., Гудима И.А., Газаев З.И., Ибишев Х.С., Митусова Е.В. Новый взгляд на этиологическую структуру острого обструктивного пиелонефрита печат. СПНиО. 2012;4.
  23. Набока Ю.Л., Митусова Е.В., Гудима И.А., Моргун П.П., Коган М.И. Динамика микробиоты мочи пациентов с острым обструктивным пиелонефритом при длительном наблюдении. Вестник урологии. 2015;(1):15-23.) https://doi.org/10.21886/2308-6424-2015-0-1-15-23
  24. Hooton T.M. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am. 2003;17(2):303-332.
  25. Hamasuna R., Takahashi S., Nagae H., Kubo T., Yamamoto S., Arakawa S., Matsumoto T. Obstructive pyelonephritis as a result of urolithiasis in J apan: Diagnosis, treatment and prognosis. Int. J. Urol. 2015;22:294-300. doi: 10.1111/iju.12666.
  26. Fisher J.F., Kavanagh K., Sobel J.D., Kauffman C.A., Newman C.A. Candida Urinary Tract Infection: Pathogenesis. Clinical Infectious Diseases. 2011;52(Supplement 6):S437-S451. doi: 10.1093/cid/cir110.
  27. Сизонов В. В., Дубров В.И., Акрамов Н.Р., Марков Н.В., Каганцов И.М., Шидаев А.Х-А. Результаты лечения новорожденных с постренальной анурией, обусловленной обструкцией грибковыми безоарами верхних мочевыводящих путей. Урология. 2020;1:С. 81-85.
  28. Kauffman C.A. Diagnosis and Management of Fungal Urinary Tract Infection. Infectious Disease Clinics of North America. 2014;28(1):61-74. doi: 10.1016/j.idc.2013.09.004.
  29. Julian L. Seifter. Chapter 22: Urinary tract obstruction. J. Larry Jameson, Joseph Loscalzo. Harrison’s Nephrology and Acid-Base Disorders, 3e (Harrison’s Specialty). 2017;262-277. ISBN: 978-1-25-983579-7
  30. Buonaiuto V.A., Marquez I., De Toro I., et al. Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study. BMC Infect. Dis. 2014;2.14.639. https://doi.org/10.1186/s12879-014-0639-4
  31. Schneeberger C., Holleman F., Geerlings S. E. Febrile urinary tract infections. Current Opinion in Infectious Diseases. 2016;29(1):80-85. Doi: 10.1097/ qco.0000000000000227.
  32. Firoozeh F., Saffari M., Neamati F., Zibaei M. Detection of virulence genes in Escherichia coli isolated from patients with cystitis and pyelonephritis. Int. J. Infect. Dis. 2014;29:219-222. doi: 10.1016/j.ijid.2014.03.1393.
  33. Naboka Y.L., Mavzyiutov A.R., Kogan M.I., Gudima I.A., Ivanov S.N., NaberK.G. Does Escherichia coli have pathogenic potential at a low level of bacteriuria in recurrent, uncomplicated urinary tract infection? Int. J. Antimicrob. Agents. 2020;105983. doi: 10.1016/j.ijantimicag.2020.105983.
  34. Johnson J.R., Porter S., Thuras P., Castanheira M. The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012). Open Forum Infect Dis. 2017;4(2):ofx089. doi: 10.1093/ofid/ofx089.
  35. Синякова Л.А, И.В. Косова, О.Б. Лоран. Роль урогенитальных инфекций в этиологии циститов и необструктивных пиелонефритов у женщин (клинико-экспериментальное исследование). Инфекции и воспаления в урологии. 2019;52-75).
  36. М.И. Коган, Ю.Л. Набока, Д.Г. Пасечник. Острый обструктивный пиелонефрит. Экспериментальная модель. 2019;222-245).
  37. Перепанова Т.С., Волкова Е.М. К вопросу патогенеза рецидивирующей инфекции нижних мочевыводящих путей. ЭКУ. 2015 ;3 URL: https://cyberleninka.ru/ article/n/k-voprosu-patogeneza-retsidiviruyuschey-infektsii-nizhnih-mochevyvodyaschih-putey
  38. Бухарин О.В., Валышев А.В., Гильмутдинова Ф.Г. Экология микроорганизмов человека. УрО РАН. Екатеринбург. 2006;401-428.
  39. Hyun M., Lee J.Y., Kim H.A., Ryu S.Y. Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients. Infect Chemother. 2019;51(2):130-141. doi: 10.3947/ic.2019.51.2.130.
  40. Maharjan G., Khadka P., Siddhi Shilpakar G., Chapagain G., Dhungana G.R. Catheter-associated urinary tract infection and obstinate biofilm producers. Can J Infect Dis Med Microbiol. 2018;2018:7624857.
  41. Sullivan M.J., Ulett G.C. Evaluation of hematogenous spread and ascending infection in the pathogenesis of acute pyelonephritis due to group B streptococcus in mice. Microb. Pathog. 2020;138:103796. Doi:10.1016/j. micpath.2019.103796.
  42. Chang U.I., Kim H.W., Noh Y.S., Wie S.H. A comparison of the clinical characteristics of elderly and nonelderly women with community-onset, nonobstructive acute pyelonephritis. Korean J Intern Med. 2015;30:372-383.
  43. Kim Y., Wie S.H., Chang U.I., Kim J., KiM., Cho Y. K., Pai H. Comparison of the clinical characteristics of diabetic and non-diabetic women with community-acquired acute pyelonephritis: A multicenter study. Journal of Infection. 2014;69(3):244-251. doi: 10.1016/j.jinf.2014.05.002.
  44. Kolman K.B. Cystitis and Pyelonephritis. Primary Care: Clinics in Office Practice. 2019;46(2):191-202. doi: 10.1016/j.pop.2019.01.001.
  45. Scholes D., Hooton T.M., Roberts P.L., Gupta K., Stapleton A.E., Stamm W.E. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005; 142(1) :20-27. doi: 10.7326/0003-4819-142-1-200501040-00008.
  46. Перепанова Т.С. Трудности лечения рецидивирующей инфекции мочевых путей. Возможности фитопрепаратов. РМЖ. 2009;84
  47. Ghafari M., Baigi V., Cheraghi Z., Doosti-Irani A. The Prevalence of Asymptomatic Bacteriuria in Iranian Pregnant Women: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(6):e0158031:22-24.
  48. Ko G.J., Ahn S.Y., Kim J.E., Cho E.J., Lee K.M., Kim H.Y., Cho G.J. Clinical Predictors Implicated in the Incidence of Acute Pyelonephritis during the Antepartum Period: A Population-Based Cohort Study. Kidney and Blood Pressure Research. 2019;1-10. doi: 10.1159/000503788.
  49. Glaser A.P., Schaeffer A.J. Urinary Tract Infection and Bacteriuria in Pregnancy. Urol. Clin. North. Am. 2015;42(4):547-560.
  50. Azami M., Jaafari Z., Masoumi M., Shohani M., Badfar G., Mahmudi L., et al. The etiology and prevalence of urinary tract infection and asymptomatic bacteriuria in pregnant women in Iran: a systematic review and Metaanalysis. BMC Urol. 2019;19(1):43.
  51. Szweda H., Jozwik M. Urinary tract infections during pregnancy - an updated overview. Dev Period Med. 2016;20(4):263-272.
  52. Kalinderi K., Delkos D., Kalinderis M., Athanasiadis A., Kalogiannidis I. Urinary tract infection during pregnancy: current concepts on a common multifaceted problem. J Obstet Gynaecol. 2018;38(4):448-453.
  53. Левченко В.В., Моргун П.П., Волдохин А.В., Абу Траби А.Я., Масловский А.С. Гестационый пиелонефрит: «традиционная» дренирующая тактика и её результаты. Вестник урологии. 2020;8(1):39-48 https://doi.org/10.21886/2308-6424-2020-8-1-39-48

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies